These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11393611)

  • 21. [Perception accuracy of BRCA1/2 mutation predisposition in breast cancer women and associated factors].
    Leblond D; Brédart A; Dolbeault S; De Pauw A; Stoppa-Lyonnet D; Sultan S
    Bull Cancer; 2012 Jun; 99(6):673-84. PubMed ID: 22641341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: review of the literature].
    Leblond D; Brédart A; Dolbeault S; De Pauw A; Stoppa Lyonnet D; Flahault C; Sultan S
    Bull Cancer; 2011 Feb; 98(2):184-98. PubMed ID: 21382771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk perception and psychological strain in women with a family history of breast cancer.
    Neise C; Rauchfuss M; Paepke S; Beier K; Lichtenegger W
    Onkologie; 2001 Oct; 24(5):470-5. PubMed ID: 11694774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRCA 1/2-negative patients who receive counseling after genetic testing have lower anxiety.
    Printz C
    Cancer; 2016 Apr; 122(8):1149. PubMed ID: 27061519
    [No Abstract]   [Full Text] [Related]  

  • 26. [Psychosocial counseling after diagnosis for non-carriers of hereditary breast cancer or ovarian cancer; is it needed?].
    van der Linden MH
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2381-4. PubMed ID: 11145091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distress and family functioning in oncogenetic counselling for hereditary and familial breast and/or ovarian cancers.
    Condello C; Gesuita R; Pensabene M; Spagnoletti I; Capuano I; Baldi C; Carle F; Contegiacomo A
    J Genet Couns; 2007 Oct; 16(5):625-34. PubMed ID: 17701329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the dyadic effects of parenting, stress, and coping on parent-child communication in families tested for hereditary breast-ovarian cancer risk.
    Hamilton JG; Mays D; DeMarco T; Tercyak KP
    Fam Cancer; 2016 Oct; 15(4):513-22. PubMed ID: 26848859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosocial aspects of familial breast and ovarian cancer: psychological guidelines for genetic testing.
    Decruyenaere M; Evers-Kiebooms G; Claes E; Denayer L; Welkenhuysen M; Legius E; Demyttenaere K
    Dis Markers; 1999 Oct; 15(1-3):152-3. PubMed ID: 10595271
    [No Abstract]   [Full Text] [Related]  

  • 31. Using genetic analysis to individualize preventive measures for breast and ovarian cancers.
    Olopade OI
    Nat Clin Pract Oncol; 2006 Apr; 3(4):182-3. PubMed ID: 16596140
    [No Abstract]   [Full Text] [Related]  

  • 32. Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer.
    Nordin K; Lidén A; Hansson M; Rosenquist R; Berglund G
    J Med Genet; 2002 Sep; 39(9):689-94. PubMed ID: 12205115
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation.
    Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
    Genet Test; 2004; 8(1):13-21. PubMed ID: 15140370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic counselling and prophylactic surgery in women from families with hereditary breast or ovarian cancer.
    Lobb E; Meiser B
    Lancet; 2004 Jun; 363(9424):1841-2. PubMed ID: 15183619
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparing Outcomes of Genetic Counseling Options in Breast and Ovarian Cancer: An Integrative Review
.
    Fournier DM; Bazzell AF; Dains JE
    Oncol Nurs Forum; 2018 Jan; 45(1):96-105. PubMed ID: 29251290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.
    Ormondroyd E; Moynihan C; Watson M; Foster C; Davolls S; Ardern-Jones A; Eeles R
    J Genet Couns; 2007 Aug; 16(4):527-38. PubMed ID: 17492498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of relationship adjustment among couples coping with a high risk of developing breast/ovarian cancer.
    Watts KJ; Sherman KA; Mireskandari S; Meiser B; Taylor A; Tucker K
    Psychol Health; 2011 May; 26 Suppl 1():21-39. PubMed ID: 20936567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.
    Bresser PJ; Seynaeve C; Van Gool AR; Niermeijer MF; Duivenvoorden HJ; van Dooren S; van Geel AN; Menke-Pluijmers MB; Klijn JG; Tibben A
    Eur J Cancer; 2007 Jan; 43(1):95-103. PubMed ID: 17095208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
    Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
    Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receipt of a false positive test result during routine screening for ovarian cancer: a teachable moment?
    Floyd A; Steffens RF; Pavlik E; Andrykowski MA
    J Clin Psychol Med Settings; 2011 Mar; 18(1):70-7. PubMed ID: 21373852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.